SCHEMBL5899593

SCHEMBL5899593

CN(CC(=O)c1ccccc1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
TSHR P16473 1/20 0.53
GAA P10253 2/20 0.52
ADAMTS5 Q9UNA0 1/20 0.51
MAPT P10636 2/20 0.50
HTT P42858 2/20 0.50
MEN1 O00255 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
HSD11B1 P28845 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA3 P07451 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA5A P35218 1/20 0.50
CA7 P43166 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899425 0.92 ALDH1A1 (0.56) KMT2ATSHRGAAADAMTS5MAPT
SCHEMBL5899607 0.89 HSD11B1 (0.57) KMT2AGAAMAPTHTTMEN1
SCHEMBL6402817 0.87 KMT2A (0.58) KMT2AGAAMAPTTDP1CA12
SCHEMBL11603483 0.87 RECQL (0.59) KMT2AHTTMEN1KEAP1NFE2L2
SCHEMBL5899682 0.86 GAA (0.50) KMT2ATSHRGAAMAPTMEN1
SCHEMBL9819498 0.84 KMT2A (0.50) KMT2ATSHRGAAMAPTHTT
SCHEMBL27628054 0.83 TDP1 (0.49) KMT2ATSHRGAAMAPTHTT
SCHEMBL11579297 0.83 POLB (0.64) KMT2ATSHRGAAMAPTHTT
SCHEMBL5899473 0.82 GAA (0.50) KMT2AGAAMAPTTDP1HSD11B1
SCHEMBL5899493 0.81 GAA (0.48) KMT2ATSHRGAAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KMT2A 1509/4885TSHR 3445/4885GAA 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.